The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInter. Pers. Regulatory News (IPF)

Share Price Information for Inter. Pers. (IPF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 106.00
Bid: 105.00
Ask: 106.00
Change: 0.50 (0.47%)
Spread: 1.00 (0.952%)
Open: 106.00
High: 106.50
Low: 105.00
Prev. Close: 105.50
IPF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issuance and amendment to Final Terms

3 Nov 2023 16:14

RNS Number : 3914S
International Personal Finance Plc
03 November 2023
 

International Personal Finance plc

Issuance of PLN 72,000,000 Senior Unsecured Floating Rate Notes due 2026 (the "Notes") and amendment to Final Terms

Further to an announcement released by International Personal Finance plc ("IPF") on 24 October 2023 at 15:19 under RNS No 1487R (the "Original Announcement"), IPF today announces that it has successfully issued PLN 72,000,000 Senior Unsecured Floating Rate Notes due 2026 (the "Notes").

Commenting on today's announcement, Chief Financial Officer, Gary Thompson said: 

"I am pleased to report the successful issuance of the PLN 72,000,000 Senior Unsecured Floating Rate Notes due 2026. The new funding is instrumental in diversifying our funding profile and opens up funding opportunities in the region."

IPF further notes that amendments have been made to the Final Terms included in the Original Announcement, to update the item "Interest Determination Date" and to clarify the proposed date for the Notes to be admitted to trading on Euronext Dublin (as outlined below).

The amended and restated Final Terms for the Notes are available for viewing by pasting the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/3914S_1-2023-11-3.pdf

The amended and restated Final Terms should be read in conjunction with the base prospectus dated 24 August 2023 relating to IPF's EUR 1,000,000,000 Euro Medium Term Note Programme (the "Base Prospectus").

A copy of the amended and restated Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

The Notes have been admitted to listing and trading on the regulated market of the Irish Stock Exchange plc (trading as Euronext Dublin) from 3 November 2023.

For further information contact:

International Personal Finance plc

Krzysztof Adamski (Group Treasurer)

+48 600400394

Rachel Moran (Investor Relations Manager)

+44 (0)113 539 5466

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus as supplemented by the Final Terms is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein. In particular, this announcement is not for distribution in the United States and the Notes have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act"). Subject to certain exceptions, Notes may not be offered, sold or delivered, directly or indirectly, in the United States or to, or for the account or benefit of U.S. persons, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the Notes in the United States.

Your right to access this service is conditional upon complying with the above.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTBLBDBXBGDGXX
Date   Source Headline
8th Apr 20241:13 pmRNSDirector/PDMR Shareholding
5th Apr 202410:00 amRNSDirector/PDMR Shareholding
4th Apr 202410:48 amRNSDirector/PDMR Shareholding
3rd Apr 20243:29 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20245:09 pmRNSDirector/PDMR Shareholding
25th Mar 20244:44 pmRNSAnnual Financial Report and Notice of AGM
21st Mar 20245:09 pmRNSDirector/PDMR Shareholding
19th Mar 20243:56 pmRNSDirector/PDMR Shareholding
18th Mar 20244:11 pmRNSDirector/PDMR Shareholding
15th Mar 202410:38 amRNSFinal Dividend Timetable Correction
14th Mar 20247:00 amRNSFinal Results and Accounts
26th Feb 20247:00 amRNSDelay of year-end results announcement
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Dec 20239:08 amRNSHolding(s) in Company
14th Dec 202311:24 amRNSPublication of Final Terms
24th Nov 20237:02 amRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSFinal Confirmation & Results of Exchange Offer
17th Nov 20233:18 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSAppointment of Joint Broker
14th Nov 20233:09 pmRNSHolding(s) in Company
8th Nov 20237:00 amRNSNotice of Investor Webinar - 7 December 2023
3rd Nov 20234:14 pmRNSIssuance and amendment to Final Terms
2nd Nov 20231:29 pmRNSCash Offer Launch
2nd Nov 20231:18 pmRNSExchange Offer
2nd Nov 20231:16 pmRNSPublication of a Prospectus
26th Oct 20237:01 amRNSRoadshow Announcement
26th Oct 20237:00 amRNSQ3 2023 Trading Update
25th Oct 20232:12 pmRNSChange of Senior Independent Director
24th Oct 20233:19 pmRNSPublication of Final Terms - Replacement Notice
24th Oct 20237:00 amRNSPublication of Final Terms
20th Oct 20237:00 amRNSUpdate on Annual General Meeting 2023 Vote
2nd Oct 20237:00 amRNSTotal Voting Rights
14th Sep 20231:46 pmRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSTotal Voting Rights
24th Aug 20234:35 pmRNSPublication of a Prospectus
1st Aug 20237:00 amRNSHalf-year Report
13th Jul 202311:14 amRNSHolding(s) in Company
3rd Jul 20232:30 pmRNSTotal Voting Rights
3rd Jul 20239:20 amRNSBlock listing Interim Review
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20234:48 pmRNSDirector/PDMR Shareholding
4th May 202311:17 amRNSDirector/PDMR Shareholding
2nd May 202312:28 pmRNSTotal Voting Rights
27th Apr 20234:27 pmRNSResult of AGM
27th Apr 20237:00 amRNSQ1 2023 Trading Update
19th Apr 20234:44 pmRNSNotice of Investor Briefing - 10 May 2023
6th Apr 20232:54 pmRNSDirector/PDMR Shareholding
4th Apr 20234:42 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:37 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.